Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adultsMinoo Mohraz, Hamed Hosseini, Payam Tabarsi et al.|BMJ Open|2022Cited by 16